INTRODUCTION
The toxic shock syndrome (TSS) encompasses high fever, sunburn-like rash, desquamation of the skin, multisystem involvement, hypotension, and in severe cases, refractory shock. TSS was first described in menstruating women who were using tampons (5) . Later on, the syndrome was recognized with increasing frequency in association with surgical wound infection. Furthermore, it is now evident that TSS or TSS-like syndromes can be caused by streptococci and staphylococci that secrete other exotoxins (8) . Staphylococcal enterotoxin B (SEB), a product of Staphylococcus aureus, is one of those toxins defined as bacterial superantigens because they stimulate a large fraction of the T-cell repertoire as a consequence of their interactions with T-cell receptors expressing specific V␤ domains (15) .
The injection of SEB in mice is a useful model to study the immunological mechanisms of superantigen-mediated shock. Indeed, BALB/c mice receiving a single injection of SEB develop prostration, piloerection, diarrhea, hypoglycemia, hypothermia, and weight loss (21, 22 , and our unpublished data). This shock syndrome is associated with a marked decrease in circulating leukocyte counts (2) and with the secretion by V␤8 ϩ T cells of several inflammatory mediators including tumor necrosis factor (TNF) and gamma interferon (IFN-␥) (20, 22, 24) .
Several observations indicate that both TNF and IFN-␥ are critically involved in the pathogenesis of SEB-induced shock. Firstly, TNF neutralization by anti-TNF antibody was found to prevent lethality following SEB administration in mice sensitized by D-galactosamine (24) . Likewise, mice deficient for the 55-kDa TNF receptor display complete resistance in the same model (25) . Secondly, the role of IFN-␥ was demonstrated by the protective effects of anti-IFN-␥ antibody on SEB-induced toxicity in mice sensitized either by D-galactosamine (22) or a previous injection of SEB (11) .
It is striking that the rates of SEB-induced lethality reported in the literature are tremendously variable. Among the factors which might influence the severity of the shock syndrome, the age of the mice, the exposure to endotoxin, and the presence of viral infection in the mouse colony might be especially important. Indeed, old mice are more sensitive to the toxic effects of SEB than young animals, most probably because they produce higher levels of TNF (3). The same mechanism could account for the potentiation of SEB toxicity in mice exposed to endotoxin (30 and our unpublished data). The possible sensitization related to ongoing viral infection is supported by the increased susceptibility to SEB of mice infected with the murine lymphocytic choriomeningitis virus (27) .
Usually, the shock syndrome induced by SEB in unsensitized mice is self-limited. As in the case of endotoxemia, the natural control of the inflammatory response is exerted at different levels and most likely involves (i) the functional inhibition of cytokine-secreting cells, (ii) the neutralization of inflammatory cytokines by soluble receptors or cytokine-receptor antagonists, and (iii) the production of substances preventing cytokine-induced damages. In this paper, we review the major feedback mechanisms which were found to down-regulate the T-cell hyperactivation induced by SEB in vivo.
ACTIVATION-INDUCED CELL DEATH AND ANERGY
Immediately after the administration of SEB, SEB-reactive T cells undergo transient activation and rapidly proliferate. Within a few days, the majority of the proliferating cells are then eliminated by a phenomenon of activation-induced cell death (17, 23, 31) . The interaction of Fas (CD95) with its ligand (FasL) is a critical event in the initiation of this process (7) as shown by the impaired elimination of SEB-reactive T cells in mouse strains deficient in either Fas (lpr mice) or Fas ligand (gld mice) (7) .
In addition to activation-induced cell death, a phenomenon of anergy which affects residual SEB-reactive T cells contributes to reduction of the response to a subsequent SEB challenge (16, 26) . Anergy of T cells is defined operationally as an incapacity to secrete interleukin-2 (IL-2) upon antigenic challenge. Although, T-cell anergy limits the numbers of T cells able to proliferate upon SEB rechallenge, we and others found that T cells made deficient in the production of IL-2 after SEB injection are in fact primed for IFN-␥ synthesis and can even mediate a lethal shock when a second injection of SEB is given 48 h after the first one (11, 12) .
Because activation-induced cell death and anergy do not limit the initial release of cytokines and in view of the persistent inflammatory potential of anergic T cells, it is not surprising that other mechanisms contribute to the down-regulation of SEB-induced T-cell activation.
HORMONAL FACTORS
Corticosterone is rapidly released after SEB injection, and there is clear evidence that endogenous glucocorticoids downregulate T-cell activation in this model. Indeed, adrenalectomized mice as well as mice pretreated with the glucocorticoid receptor antagonist RU-38486 (mifepristone) are extremely sensitive to SEB, as indicated by high lethality after a single injection of the superantigen. Moreover, administration of exogenous glucocorticoids prevents death induced by SEB challenge in D-galactosamine-sensitized mice (13) . The protective effects of glucocorticoids have been attributed both to the inhibition of cytokine synthesis by activated T cells and to their capacity to promote activation-induced cell death (6, 13, 19) .
ANTI-INFLAMMATORY CYTOKINES
IL-4, IL-10, IL-13, and transforming growth factor ␤ (TGF-␤) are considered the major anti-inflammatory cytokines. During SEB-induced shock in mice, the synthesis of IL-10 by CD4
ϩ T cells was shown to represent an important regulatory mechanism limiting the release of IFN-␥. Indeed, neutralization of endogenous IL-10 by injection of anti-IL-10 antibody significantly enhanced IFN-␥ production and SEBinduced lethality. Both phenomena appeared to be related, as lethality could be prevented by injection of anti-IFN-␥ antibody (9) . In agreement with these observations, the enhanced production of endogenous IL-10 during murine AIDS and administration of exogenous recombinant IL-10 to D-galactosamine-sensitized mice were found to alleviate superantigenmediated shock (1, 4), providing further evidence for a protective role for IL-10 in this setting.
Granulocyte colony-stimulating factor (G-CSF) is another cytokine able to protect against the toxic effects of SEB, as administration of recombinant G-CSF to D-galactosamine-sensitized mice was shown to prevent SEB-induced lethality. This G-CSF-mediated protection probably involves an action on T cells, as suggested by the decreased IL-2 levels in serum in response to SEB challenge (2, 18) .
NITRIC OXIDE
SEB-induced shock in mice proved to be a relevant model to investigate the regulatory effects of nitric oxide (NO) on T cells in vivo. The systemic release of NO metabolites in this model was shown to be directly related to a synergistic effect of IFN-␥ and TNF on NO synthesis (10) . When a competitive inhibitor of NO synthase (N-nitro-L-arginine methyl ester [L-NAME]) was administered to block NO production, the toxicity of SEB was dramatically enhanced, as indicated by a 95% lethality rate. This was associated with sustained production of IFN-␥ and TNF, which was responsible for SEB-induced lethality, as indicated by experiments using anti-IFN-␥ and anti-TNF antibodies. We concluded from this study that NO overproduction during SEB-induced shock is a feedback mechanism that limits the synthesis of the T-cell-derived inflammatory cytokines responsible for SEB toxicity (10) . Moreover NO overproduction may also be protective by counteracting the prothrombotic properties of TNF and IFN-␥ (29), since NO is a vasoactive mediator that inhibits platelet aggregation and adhesion (14, 28) .
CONCLUDING REMARKS
Glucocorticoids, IL-10, and NO were shown to play major immunoregulatory roles in the mouse model of SEB-induced shock. Thus, the endogenous production of these substances during acute infections caused by microorganisms producing T-cell superantigens could exert both deleterious and beneficial effects. On one hand, they inhibit host immune defenses required to eliminate microorganisms, but on the other hand, they limit the hyperactivation of the immune system, which causes shock, such as is the case with TSS. This also applies to the phenomena of activation-induced cell death and anergy, which reduce T-cell responses.
It is important to keep in mind these notions when considering new therapeutic strategies for severe sepsis, as their efficiency might be influenced by their interference with immunoregulatory pathways involving either the production of antiinflammatory mediators or the elimination and inactivation of superantigen-reactive T cells.
